AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: PETER BENESH
These are the best of times at Varian Medical Systems, the nation's top maker of radiation equipment to kill cancer tumors.
The numbers speak for themselves: Coming off a fiscal 2003 that was the Palo Alto, Calif., company's best in more than a decade, earnings in the first quarter climbed another 37% on the best revenue gain (29%) in years.
That growth stems from firm's strategy, says CEO Richard Levy.
"Many companies develop a product, then try to figure out where it will help," he said. "We understand the problem first and do what it takes to find the solution."
Varian's latest "multileaf collimator" is just such a technology.
Early anti-cancer radiation de-vices took a blunderbuss approach to zapping tumors, hitting good cells around the diseased area. The multileaf collimator is the sniper rifle of radiation therapy.